法爾勝(000890.SZ)擬轉讓摩山保理100%股權予匯金創展
格隆匯1月23日丨法爾勝(000890.SZ)公佈,公司擬向深圳匯金創展商業保理有限公司(“匯金創展”)轉讓公司持有的全資子公司上海摩山商業保理有限公司(“摩山保理”)100%股權,雙方就上述事項於2020年1月22日簽署了《關於轉讓上海摩山商業保理有限公司股權事宜之框架協議》(“框架協議”)。
上海摩山商業保理有限公司經營範圍:進出口保理業務;國內及離岸保理業務;與商業保理相關的諮詢服務;經許可的其他相關業務。
此次交易若順利完成,將有效化解公司保理業務風險,改善公司經營現狀,提升公司持續經營能力,推進公司轉型發展,符合公司和全體股東的利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.